Details for: TYLENOL SINUS PLUS MUCOUS RELIEF
Product description
Product name: TYLENOL SINUS PLUS MUCOUS RELIEF
Company name: MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
DIN: 02347377
Status: Cancelled Pre Market
Status date: 2016-01-22
| Active ingredient(s) | Strength |
|---|---|
| ACETAMINOPHEN | 325 MG |
| GUAIFENESIN | 200 MG |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 30 MG |
Resources
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
For health care professionals
| Resource | Description |
|---|---|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
For researchers
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
All resources
| Resource | Description |
|---|---|
| Search Clinical Information | After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
| Report a serious adverse drug reaction (for hospitals) |
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| Resource | Description |
|---|---|
| Report a side effect |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|